Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel
Clinical trial NCT03183492 · WITHDRAWN
Trial details
- NCT number
- NCT03183492
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-07
- Primary completion
- 2019-01-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.